SLFN13 and breast cancer: An analysis of “The Cancer Genome Atlas” database revealed the downregulation of SLFN13 in breast cancer, lung squamous carcinoma, prostate cancer, and rectal carcinoma, whereas the protein was upregulated in pancreatic- and renal-cell carcinoma [11].